Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$22,448,212
-$2,765,487 QoQ
Shares Held
177,681
-1.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#314
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Dec 31, 2021CallValue
$11,834
CallShares
163
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026M&T Bank Corp holds $1,400,301,000 across 15 Drug Manufacturers - General names. GILD ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,544,780 | $392,327,766 | |
| 2 | LLY |
ELI LILLY & Co
|
261,864 | $314,087,555 | |
| 3 | ABBV |
AbbVie Inc.
|
947,647 | $238,465,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,434,057 | $184,276,321 | |
| 5 | PFE |
Pfizer Inc
|
2,717,196 | $65,430,073 | |
| 6 | AMGN |
Amgen Inc
|
162,127 | $58,709,426 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
759,648 | $43,770,913 | |
| 8 | NVS |
Novartis AG
|
183,359 | $28,736,020 |
All Filings in GILD
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,448,212 | 177,681 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $25,213,699 | 180,912 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $23,460,641 | 191,141 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $18,940,596 | 170,636 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,999,549 | 189,407 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,980,619 | 196,168 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $18,582,530 | 201,175 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $16,177,091 | 192,952 | Shares | Defined | 2024-11-19 | |
| 2024-06-30 | $12,830,680 | 187,009 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $14,391,936 | 196,477 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $17,393,004 | 214,702 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $16,153,986 | 215,559 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $17,355,390 | 225,190 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $19,102,263 | 230,231 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $20,266,347 | 236,067 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,980,430 | 226,624 | Shares | Defined | 2022-11-17 | |
| 2022-06-30 | $13,729,862 | 235,802 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $16,151,610 | 271,684 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $42,547,711 | 585,976 | Shares | Defined | 2022-02-07 | |
| 2021-12-31 | $11,834 | 163 | Call | Defined | 2022-02-07 | |
| 2021-09-30 | $6,494 | 93 | Call | Defined | 2021-10-28 | |
| 2021-09-30 | $37,105,572 | 531,218 | Shares | Defined | 2021-10-28 | |
| 2021-06-30 | $22,635,034 | 328,711 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $21,814,560 | 337,530 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $20,146,303 | 345,800 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $315 | 5 | Call | Defined | 2020-11-06 | |
| 2020-09-30 | $26,208,048 | 414,750 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $33,223,611 | 431,812 | Shares | Defined | 2020-07-29 | |
| 2020-06-30 | $384 | 5 | Call | Defined | 2020-07-29 | |
| 2020-03-31 | $373 | 5 | Call | Defined | 2020-05-14 | |
| 2020-03-31 | $51,918,125 | 694,464 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||